HB3486 EngrossedLRB097 08349 RLC 51314 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 204 as follows:
 
6    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
7    Sec. 204. (a) The controlled substances listed in this
8Section are included in Schedule I.
9    (b) Unless specifically excepted or unless listed in
10another schedule, any of the following opiates, including their
11isomers, esters, ethers, salts, and salts of isomers, esters,
12and ethers, whenever the existence of such isomers, esters,
13ethers and salts is possible within the specific chemical
14designation:
15        (1) Acetylmethadol;
16        (1.1) Acetyl-alpha-methylfentanyl
17    (N-[1-(1-methyl-2-phenethyl)-
18    4-piperidinyl]-N-phenylacetamide);
19        (2) Allylprodine;
20        (3) Alphacetylmethadol, except
21    levo-alphacetylmethadol (also known as levo-alpha-
22    acetylmethadol, levomethadyl acetate, or LAAM);
23        (4) Alphameprodine;

 

 

HB3486 Engrossed- 2 -LRB097 08349 RLC 51314 b

1        (5) Alphamethadol;
2        (6) Alpha-methylfentanyl
3    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
4    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
5    propanilido) piperidine;
6        (6.1) Alpha-methylthiofentanyl
7    (N-[1-methyl-2-(2-thienyl)ethyl-
8    4-piperidinyl]-N-phenylpropanamide);
9        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
10        (7.1) PEPAP
11    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
12        (8) Benzethidine;
13        (9) Betacetylmethadol;
14        (9.1) Beta-hydroxyfentanyl
15    (N-[1-(2-hydroxy-2-phenethyl)-
16    4-piperidinyl]-N-phenylpropanamide);
17        (10) Betameprodine;
18        (11) Betamethadol;
19        (12) Betaprodine;
20        (13) Clonitazene;
21        (14) Dextromoramide;
22        (15) Diampromide;
23        (16) Diethylthiambutene;
24        (17) Difenoxin;
25        (18) Dimenoxadol;
26        (19) Dimepheptanol;

 

 

HB3486 Engrossed- 3 -LRB097 08349 RLC 51314 b

1        (20) Dimethylthiambutene;
2        (21) Dioxaphetylbutyrate;
3        (22) Dipipanone;
4        (23) Ethylmethylthiambutene;
5        (24) Etonitazene;
6        (25) Etoxeridine;
7        (26) Furethidine;
8        (27) Hydroxpethidine;
9        (28) Ketobemidone;
10        (29) Levomoramide;
11        (30) Levophenacylmorphan;
12        (31) 3-Methylfentanyl
13    (N-[3-methyl-1-(2-phenylethyl)-
14    4-piperidyl]-N-phenylpropanamide);
15        (31.1) 3-Methylthiofentanyl
16    (N-[(3-methyl-1-(2-thienyl)ethyl-
17    4-piperidinyl]-N-phenylpropanamide);
18        (32) Morpheridine;
19        (33) Noracymethadol;
20        (34) Norlevorphanol;
21        (35) Normethadone;
22        (36) Norpipanone;
23        (36.1) Para-fluorofentanyl
24    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
25    4-piperidinyl]propanamide);
26        (37) Phenadoxone;

 

 

HB3486 Engrossed- 4 -LRB097 08349 RLC 51314 b

1        (38) Phenampromide;
2        (39) Phenomorphan;
3        (40) Phenoperidine;
4        (41) Piritramide;
5        (42) Proheptazine;
6        (43) Properidine;
7        (44) Propiram;
8        (45) Racemoramide;
9        (45.1) Thiofentanyl
10    (N-phenyl-N-[1-(2-thienyl)ethyl-
11    4-piperidinyl]-propanamide);
12        (46) Tilidine;
13        (47) Trimeperidine;
14        (48) Beta-hydroxy-3-methylfentanyl (other name:
15    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
16    N-phenylpropanamide).
17    (c) Unless specifically excepted or unless listed in
18another schedule, any of the following opium derivatives, its
19salts, isomers and salts of isomers, whenever the existence of
20such salts, isomers and salts of isomers is possible within the
21specific chemical designation:
22        (1) Acetorphine;
23        (2) Acetyldihydrocodeine;
24        (3) Benzylmorphine;
25        (4) Codeine methylbromide;
26        (5) Codeine-N-Oxide;

 

 

HB3486 Engrossed- 5 -LRB097 08349 RLC 51314 b

1        (6) Cyprenorphine;
2        (7) Desomorphine;
3        (8) Diacetyldihydromorphine (Dihydroheroin);
4        (9) Dihydromorphine;
5        (10) Drotebanol;
6        (11) Etorphine (except hydrochloride salt);
7        (12) Heroin;
8        (13) Hydromorphinol;
9        (14) Methyldesorphine;
10        (15) Methyldihydromorphine;
11        (16) Morphine methylbromide;
12        (17) Morphine methylsulfonate;
13        (18) Morphine-N-Oxide;
14        (19) Myrophine;
15        (20) Nicocodeine;
16        (21) Nicomorphine;
17        (22) Normorphine;
18        (23) Pholcodine;
19        (24) Thebacon.
20    (d) Unless specifically excepted or unless listed in
21another schedule, any material, compound, mixture, or
22preparation which contains any quantity of the following
23hallucinogenic substances, or which contains any of its salts,
24isomers and salts of isomers, whenever the existence of such
25salts, isomers, and salts of isomers is possible within the
26specific chemical designation (for the purposes of this

 

 

HB3486 Engrossed- 6 -LRB097 08349 RLC 51314 b

1paragraph only, the term "isomer" includes the optical,
2position and geometric isomers):
3        (1) 3,4-methylenedioxyamphetamine
4    (alpha-methyl,3,4-methylenedioxyphenethylamine,
5    methylenedioxyamphetamine, MDA);
6        (1.1) Alpha-ethyltryptamine
7    (some trade or other names: etryptamine;
8    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
9    3-(2-aminobutyl)indole; a-ET; and AET);
10        (2) 3,4-methylenedioxymethamphetamine (MDMA);
11        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
12    (also known as: N-ethyl-alpha-methyl-
13    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
14    and MDEA);
15        (2.2) N-Benzylpiperazine (BZP);
16        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
17        (4) 3,4,5-trimethoxyamphetamine (TMA);
18        (5) (Blank);
19        (6) Diethyltryptamine (DET);
20        (7) Dimethyltryptamine (DMT);
21        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
22        (9) Ibogaine  (some trade and other names:
23    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
24    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
25    indole; Tabernanthe iboga);
26        (10) Lysergic acid diethylamide;

 

 

HB3486 Engrossed- 7 -LRB097 08349 RLC 51314 b

1        (10.5) Salvia divinorum (meaning all parts of the plant
2    presently classified botanically as Salvia divinorum,
3    whether growing or not, the seeds thereof, any extract from
4    any part of that plant, and every compound, manufacture,
5    salts, isomers, and salts of isomers whenever the existence
6    of such salts, isomers, and salts of isomers is possible
7    within the specific chemical designation, derivative,
8    mixture, or preparation of that plant, its seeds or
9    extracts);
10        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
11        (12) Peyote (meaning all parts of the plant presently
12    classified botanically as Lophophora williamsii Lemaire,
13    whether growing or not, the seeds thereof, any extract from
14    any part of that plant, and every compound, manufacture,
15    salts, derivative, mixture, or preparation of that plant,
16    its seeds or extracts);
17        (13) N-ethyl-3-piperidyl benzilate (JB 318);
18        (14) N-methyl-3-piperidyl benzilate;
19        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
20    (also known as N-hydroxy-alpha-methyl-
21    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
22        (15) Parahexyl; some trade or other names:
23    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
24    dibenzo (b,d) pyran; Synhexyl;
25        (16) Psilocybin;
26        (17) Psilocyn;

 

 

HB3486 Engrossed- 8 -LRB097 08349 RLC 51314 b

1        (18) Alpha-methyltryptamine (AMT);
2        (19) 2,5-dimethoxyamphetamine
3    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
4        (20) 4-bromo-2,5-dimethoxyamphetamine
5    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
6    4-bromo-2,5-DMA);
7        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
8    Some trade or other names: 2-(4-bromo-
9    2,5-dimethoxyphenyl)-1-aminoethane;
10    alpha-desmethyl DOB, 2CB, Nexus;
11        (21) 4-methoxyamphetamine
12    (4-methoxy-alpha-methylphenethylamine;
13    paramethoxyamphetamine; PMA);
14        (22) (Blank);
15        (23) Ethylamine analog of phencyclidine.
16    Some trade or other names:
17    N-ethyl-1-phenylcyclohexylamine,
18    (1-phenylcyclohexyl) ethylamine,
19    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
20        (24) Pyrrolidine analog of phencyclidine. Some trade
21    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
22    PHP;
23        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
24        (26) 2,5-dimethoxy-4-ethylamphetamine
25    (another name: DOET);
26        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine

 

 

HB3486 Engrossed- 9 -LRB097 08349 RLC 51314 b

1    (another name: TCPy);
2        (28) (Blank);
3        (29) Thiophene analog of phencyclidine (some trade
4    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
5    2-thienyl analog of phencyclidine; TPCP; TCP);
6        (30) Bufotenine (some trade or other names:
7    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
8    3-(2-dimethylaminoethyl)-5-indolol;
9    5-hydroxy-N,N-dimethyltryptamine;
10    N,N-dimethylserotonin; mappine);
11        (31)  1-Pentyl-3-(1-naphthoyl)indole 
12    Some trade or other names: JWH-018; 
13        (32) 1-Butyl-3-(1-naphthoyl)indole 
14    Some trade or other names: JWH-073. 
15    (e) Unless specifically excepted or unless listed in
16another schedule, any material, compound, mixture, or
17preparation which contains any quantity of the following
18substances having a depressant effect on the central nervous
19system, including its salts, isomers, and salts of isomers
20whenever the existence of such salts, isomers, and salts of
21isomers is possible within the specific chemical designation:
22        (1) mecloqualone;
23        (2) methaqualone; and
24        (3) gamma hydroxybutyric acid.
25    (f) Unless specifically excepted or unless listed in
26another schedule, any material, compound, mixture, or

 

 

HB3486 Engrossed- 10 -LRB097 08349 RLC 51314 b

1preparation which contains any quantity of the following
2substances having a stimulant effect on the central nervous
3system, including its salts, isomers, and salts of isomers:
4        (1) Fenethylline;
5        (2) N-ethylamphetamine;
6        (3) Aminorex (some other names:
7    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
8    4-5-dihydro-5-phenyl-2-oxazolamine) and its
9    salts, optical isomers, and salts of optical isomers;
10        (4) Methcathinone (some other names:
11    2-methylamino-1-phenylpropan-1-one;
12    Ephedrone; 2-(methylamino)-propiophenone;
13    alpha-(methylamino)propiophenone; N-methylcathinone;
14    methycathinone; Monomethylpropion; UR 1431) and its
15    salts, optical isomers, and salts of optical isomers;
16        (5) Cathinone (some trade or other names:
17    2-aminopropiophenone; alpha-aminopropiophenone;
18    2-amino-1-phenyl-propanone; norephedrone) or a
19    derivative of cathinone, including any compound 
20    (not being bupropion, diethylpropion or 
21    pyrovalerone) structurally derived from 2-amino- 
22    1-phenyl-1-propanone by modification in any of 
23    the following ways: 
24        (i) by substitution in the phenyl ring 
25    to any extent with alkyl, alkoxy, alkylenedioxy, 
26    haloalkyl or halide substituents, whether 

 

 

HB3486 Engrossed- 11 -LRB097 08349 RLC 51314 b

1    or not further substituted in the phenyl ring 
2    by one or more other univalent substituents; 
3        (ii) by substitution at the 3-position 
4    with an alkyl substituent; 
5        (iii) by substitution at the nitrogen atom 
6    with alkyl or dialkyl groups, or by inclusion of the 
7    nitrogen atom in a cyclic structure; 
8        (iv) Naphthylpyrovalerone and its salts, optical  
9    isomers, and salts of optical isomers 
10    (some other names: Naphyrone, NRG-1)
11        (6) N,N-dimethylamphetamine (also known as:
12    N,N-alpha-trimethyl-benzeneethanamine;
13    N,N-alpha-trimethylphenethylamine);
14        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
15    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
16    (g) Temporary listing of substances subject to emergency
17scheduling. Any material, compound, mixture, or preparation
18that contains any quantity of the following substances:
19        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
20    (benzylfentanyl), its optical isomers, isomers, salts,
21    and salts of isomers;
22        (2) N-[1(2-thienyl)
23   methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
24   its optical isomers, salts, and salts of isomers.
25(Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07;
2696-347, eff. 1-1-10; 96-1285, eff. 1-1-11.)